Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07175324

Oct-A and Perimetry in Multiple Sclerosis

Correlation Between Optical Coherence Tomography Angiography and Visual Field Changes in Patients With Multiple Sclerosis

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
32 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This study aims to assess retinal vascular density using OCT-A and correlate these parameters with visual field changes in MS patients with and without a history of ON

Detailed description

The aim of this work is to investigate the correlation between visual field parameters and optical coherence tomography angiography (OCT-A) findings in patients with multiple sclerosis (MS). MS is a chronic autoimmune demyelinating disease that frequently involves the visual pathway, often presenting with optic neuritis (ON) and subsequent neurodegeneration. OCT-A, a non-invasive imaging modality, enables detailed visualization and quantification of retinal microvasculature, particularly the superficial and deep capillary plexuses, which supply the retinal ganglion cells and nerve fiber layers. Previous studies have demonstrated reduced retinal vessel density and thinning of retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) in MS patients, reflecting neuro-axonal damage and microvascular impairment. However, the relationship between these structural and vascular changes and functional visual outcomes, such as visual field loss, remains to be fully elucidated. This study aims to assess retinal vascular density using OCT-A and correlate these parameters with visual field indices in MS patients with and without a history of ON. By analyzing inter-eye differences and comparing with MS patients, the research seeks to clarify whether OCT-A metrics can serve as reliable biomarkers for visual dysfunction and disease progression in MS. Understanding this correlation could improve early detection of neuroretinal damage, guide monitoring of disease activity, and potentially inform therapeutic strategies.

Conditions

Interventions

TypeNameDescription
DEVICEoptical coherence tomography angiographycorrelation between OctA and Visual field changes in Multiple Sclerosis
DEVICEVisual Field PerimetryCorrelation between OctA and Visual field changes in Multiple sclerosis

Timeline

Start date
2025-09-01
Primary completion
2026-09-01
Completion
2026-10-01
First posted
2025-09-16
Last updated
2025-09-16

Source: ClinicalTrials.gov record NCT07175324. Inclusion in this directory is not an endorsement.